Newsfeeds - Spark Newswire

1 minute read

U.S. FDA removes Clinical Hold on Finch’s investigational new drug (IND) application for CP101

Today, 8:18 PM

The U.S. Food and Drug Administration (FDA) has removed the clinical hold on Finch Therapeutics Group (NASDAQ: FNCH) investigational new drug (IND) application for CP101 in the prevention of recurrent C. difficile infection (CDI).

FNCH

4 minute read

FDA
News

Finch Therapeutics Announces Removal Of FDA Clinical Hold On CP101 IND

By Benzinga Newsdesk

Today, 8:18 PM

Finch Therapeutics Announces Removal of FDA Clinical Hold on CP101 IND SOMERVILLE, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. ("Finch" or "Finch Therapeutics")

FNCH

48 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 8:18 PM

During Thursday, 849 stocks hit new 52-week lows.

AADI

33 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 8:18 PM

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

1 minute read

Finch Therapeutics Cuts 20% Workforce, Realigns Focus On C. Diff, Autism Programs

By Vandana Singh

Today, 8:18 PM

Finch Therapeutics Group Inc (NASDAQ:FNCH) announced the layoff of 20% of its staff in a regulatory filing. The cuts will…

FNCH

15 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 8:18 PM

On Tuesday, 242 companies hit new 52-week lows.

ACRX

1 minute read

Jefferies Maintains Buy on Finch Therapeutics Group, Lowers Price Target to $17

By Benzinga Newsdesk

Today, 8:18 PM

Jefferies analyst Chris Howerton maintains Finch Therapeutics Group (NASDAQ:FNCH) with a Buy and lowers the price target from $29 to $17.

FNCH

2 minute read

Earnings

Finch Therapeutics Group Earnings Perspective: Return On Capital Employed

By Benzinga Insights

Today, 8:18 PM

Finch Therapeutics Group (NASDAQ:FNCH) brought in sales totaling $806.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 91.41%, resulting in a loss of $19.05 million.

FNCH